We can be your premier partner for Clinical Research in Tampa Bay. At Guardian Angel, the trials are conducted by our experienced Principal Investigators. They are passionate about the research process and specialize in a wide variety of therapeutic areas. With a dedicated professional team, we take pride in making sure that we can meet or exceed our sponsor’s expectations.
We are highly proactive in the clinical research industry and attend all major industry meetings taking place in the country. Contact us for partnering.
Guardian Angel Research Center is a leading clinical research organization. Our team comprises of skilled healthcare professionals who are committed to delivering top-notch medical research services. We strive to provide our patients with the highest quality of care and expertise.
Our team comprises Board-Certified Physicians, research coordinators, phlebotomists, registered nurses, medical assistants, and office managers, who work together to ensure exceptional patient care.
Located just 5 miles from the Tampa International Airport, our facility is easily accessible via major roadways and public transportation, and transportation assistance is also available for your convenience. We are conveniently located in close proximity to St. Joseph Hospital and Florida Hospital Carrollwood, providing you with access to the best medical research team.
75+
Studies Conducted
1500+
Patients Enrolled
99.3%
Retention Rate
99.7%
Patient Satisfaction
We have the infrastructure, technologies, highly trained personnel, and volunteers to conduct clinical trials in Tampa. These are some of our satisfied sponsors and CROs.
We are highly proactive in the clinical research industry and attend all major industry meetings taking place in the country. Contact us for more information.
The following studies are currently recruiting participants. Contact us today for detailed information.
Phase: Phase 3 / Start Date: May 2025
Diabetic foot ulcers (DFUs) are ostensibly the most challenging types of chronic ulcerations to manage, given their multifactorial nature. Thorough, systematic assessment of a patient with a DFU is essential to developing a comprehensive plan of care.
Enrollment OpenPhase: Phase 3 / Start Date: Jan 2025
Enrollment OpenPhase: Phase 3 / Start Date: Feb 2024
Enrollment OpenPhase: Phase 3 / Start Date: Jun 2026
Enrollment OpenPhase: Phase 3 / Start Date: Jun 2026
Enrollment Open
